Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR)

157 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q2 2022.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 55,366,705 shares of 207,440,936 outstanding shares and own 26.69% of the company stock.
Largest 10 shareholders include WASATCH ADVISORS INC (7,546,008 shares), Deep Track Capital, LP (6,000,000 shares), Meditor Group Ltd (4,468,835 shares), VANGUARD GROUP INC (4,296,198 shares), BlackRock Inc. (4,294,232 shares), Bellevue Group AG (4,235,264 shares), MILLENNIUM MANAGEMENT LLC (2,706,290 shares), Ikarian Capital, LLC (2,054,602 shares), PLATINUM INVESTMENT MANAGEMENT LTD (1,623,440 shares), and Paradigm Biocapital Advisors LP (1,408,050 shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.